Bonini M.Bachert C.Baena-Cagnani C.E.Bedbrook A.Brozek J.L.Canonica G.W.Cruz A.A.Fokkens W.J.Wijk R.G.V.Grouse L.Hellings P.W.Howarth P.Kalayci O.Khaltaev N.Kuna P.Linnemann D.L.Nekam K.Palkonen S.Papadopoulos N.G.Popov T.A.Price D.Pinto J.R.Rasi G.Ryan D.Samolinski B.Scadding G.K.Schünemann H.J.Thomas D.M.Triggiani M.Yorgancioglu A.Yusuf O.M.Zuberbier T.Pawankar R.Bousquet J.Bonini S.2024-07-222024-07-22201314736322http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17396[No abstract available]EnglishAll Open Access; Bronze Open AccessAthletesEvidence-Based PracticeHumansLondonPrevalenceRhinitis, Allergic, PerennialSportsallergenantihistaminic agentbeta 2 adrenergic receptor stimulating agentbronchodilating agentcorticosteroidephedrinelong acting drugmethylephedrinepseudoephedrineshort acting drugsteroidvasoconstrictor agentaccuracyallergic rhinitisarticleasthmaathletebronchospasmdopingdrug urine levelexercise induced asthmaexercise induced bronchoconstrictionfatiguegamehumanhumiditypollutantpractice guidelineprevalencepriority journalquality of liferespiratory tract diseasesedationsensitizationside effecttemperaturetrainingWhat we should learn from the London OlympicsArticle10.1097/ACI.0b013e32835c1b73